Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 331 AL 345

Intrathecal Immunoselective Nanopheresis for Alzheimer's Disease: What and How? Why and When?

Menendez-Gonzalez M.

Int J Mol Sci. 2024 Oct 2;25(19):10632. doi: 10.3390/ijms251910632.

Melatonin in Alzheimer's Disease: Literature Review and Therapeutic Trials

Steinbach MJ, Denburg NL.

J Alzheimers Dis. 2024;101(s1):S193-S204. doi: 10.3233/JAD-230760.

CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer's Disease Treatment: A Systematic Review of Available Clinical Data

Thitilertdecha P, Brimson JM.

J Alzheimers Dis. 2024;101(s1):S115-S128. doi: 10.3233/JAD-230994.

CMS121, a Novel Drug Candidate for the Treatment of Alzheimer's Disease and Age-Related Dementia

Currais A, Raschke W, Maher P.

J Alzheimers Dis. 2024;101(s1):S179-S192. doi: 10.3233/JAD-231062.

Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease

Feldman HH, Messer K, Qiu Y, Sabbagh M, Galasko D, Turner RS, Lopez O, Smith A, Durant J, Lupo JL, Revta C, Balasubramanian A, Kuehn-Wache K, Wassmann T, Schell-Mader S, Jacobs DM, Salmon DP, Léger G, DeMarco ML, Weber F; ADCS VIVA-MIND Study Group.

J Alzheimers Dis. 2024;101(s1):S79-S93. doi: 10.3233/JAD-231126.

BACE Inhibitor Clinical Trials for Alzheimer's Disease

Watkins EA, Vassar R.

J Alzheimers Dis. 2024;101(s1):S41-S52. doi: 10.3233/JAD-231258.

Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach

Alghamdi M, Braidy N.

J Alzheimers Dis. 2024;101(s1):S467-S477. doi: 10.3233/JAD-231277.

Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease

Morató X, Tartari JP, Pytel V, Boada M.

J Alzheimers Dis. 2024;101(s1):S285-S298. doi: 10.3233/JAD-231372.

Alzheimer's Disease and (Phyto) Estrogen Treatment: Modification of Effects by Age, Type of Treatment, and Duration of Use

Kuck MJ, Begde A, Hawkins K, Hogervorst E.

J Alzheimers Dis. 2024;101(s1):S217-S234. doi: 10.3233/JAD-231415.

Targeting Metals in Alzheimer's Disease: An Update

Du B, Chen K, Wang W, Lei P.

J Alzheimers Dis. 2024;101(s1):S141-S154. doi: 10.3233/JAD-240140.

Amyloid-Directed Antibodies: Past, Present, and Future

Noorda K, Noorda K, Sabbagh MN, Bertelson J, Singer J, Decourt B.

J Alzheimers Dis. 2024;101(s1):S3-S22. doi: 10.3233/JAD-240189.

Hypercholesterolemia and Alzheimer's Disease: Unraveling the Connection and Assessing the Efficacy of Lipid-Lowering Therapies

Pappolla MA, Refolo L, Sambamurti K, Zambon D, Duff K.

J Alzheimers Dis. 2024;101(s1):S371-S393. doi: 10.3233/JAD-240388.

Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias

Tahmi M, Benitez R, Luchsinger JA.

J Alzheimers Dis. 2024;101(s1):S345-S356. doi: 10.3233/JAD-240495.

Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies

Pappolla MA, Martins RN, Poeggeler B, Omar RA, Perry G.

J Alzheimers Dis. 2024;101(s1):S155-S178. doi: 10.3233/JAD-240659.

Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use

Sayfullaeva J, McLoughlin J, Kwakowsky A.

J Alzheimers Dis. 2024;101(s1):S235-S261. doi: 10.3233/JAD-240899.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias